Introducing PCAS (EPA:PCA), The Stock That Zoomed 224% In The Last Five Years

When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really flourishing, you can make more than 100%. Long term PCAS SA (EPA:PCA) shareholders would be well aware of this, since the stock is up 224% in five years. In contrast, the stock has fallen 9.3% in the last 30 days. The company reported its financial results recently; you can catch up on the latest numbers by reading our company report.

View our latest analysis for PCAS

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

During five years of share price growth, PCAS actually saw its EPS drop 29% per year. This was, in part, due to extraordinary items impacting earning in the last twelve months. This means it’s unlikely the market is judging the company based on earnings growth. Since the change in EPS doesn’t seem to correlate with the change in share price, it’s worth taking a look at other metrics.

In contrast revenue growth of 5.8% per year is probably viewed as evidence that PCAS is growing, a real positive. It’s quite possible that management are prioritizing revenue growth over EPS growth at the moment.

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

ENXTPA:PCA Income Statement, September 18th 2019
ENXTPA:PCA Income Statement, September 18th 2019

Take a more thorough look at PCAS’s financial health with this free report on its balance sheet.

What about the Total Shareholder Return (TSR)?

We’d be remiss not to mention the difference between PCAS’s total shareholder return (TSR) and its share price return. The TSR attempts to capture the value of dividends (as if they were reinvested) as well as any spin-offs or discounted capital raisings offered to shareholders. Its history of dividend payouts mean that PCAS’s TSR of 238% over the last 5 years is better than the share price return.

A Different Perspective

Investors in PCAS had a tough year, with a total loss of 19%, against a market gain of about 6.6%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Longer term investors wouldn’t be so upset, since they would have made 28%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. You could get a better understanding of PCAS’s growth by checking out this more detailed historical graph of earnings, revenue and cash flow.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on FR exchanges.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.